Better Odds and More Hope for Breast Cancer Patients

The UW Carbone Cancer Center, Wisconsin’s only comprehensive cancer center, is at the forefront of breast cancer research and treatment every day.

UW physicians and dedicated staff take pride in truly combining personal care with the newest technology. Every patient with cancer is offered participation in research, which includes a range of clinical trials, as well as those studies evaluating the quality of life and long-term outcomes of aggressive cancer treatment.

The UW Carbone Cancer Center’s vision for breast cancer treatment is an evolution into a breast cancer program which is uniquely different from a traditional treatment facility. The cornerstone for creating this innovative breast center is a novel research platform, which will support excellence in clinical care and faculty development as well as provide a revolutionary approach to patient care and improved outcomes.

The mission for this program is clear — to identify characteristics that make each patient unique and to use this information to fully customize cancer care. And the goal is to use customization to optimize screening, diagnosis, treatment and survivorship, and to lead in Wisconsin and nationally.

By contributing to this worthy area of need, you’ll make a real difference, and help to move the UW forward.

$

Progress

1% funded

$26,193raised of $20.0M goal

55 donors

Contact

For questions about this initiative, please contact:

Brad Jolin
1-608-308-5323

Share this Initiative

Related Stories

In essence, the Wisconsin Idea states that the university should improve people’s lives well beyond the classroom. And while many alumni, students, and faculty have taken this principle to heart, Robert Dempsey, professor and chair of the Department of Neurological Surgery at UW–Madison, really embodies it. The World Health Organization, in fact, recently named him… Read more »

Cancers are typically classified based on their tissue of origin, and that determines treatment plans. Although that practice is unlikely to end anytime soon, tumor classifications based on genetics are gaining traction and could lead to more effective, personalized treatments for patients. “In recent years, we have recognized that even within one organ type of… Read more »

They are one of the most influential federal agencies working in the U.S. healthcare industry—and they wanted to know what Dr. Amy Kind’s research had uncovered. So, naturally, she and her colleagues headed to the Centers for Medicare and Medicaid Services to present findings and answer questions.